EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 29.43
March 31, 2026 27.78
December 31, 2025 22.59
September 30, 2025 20.22
June 30, 2025 15.08
March 31, 2025 12.07
December 31, 2024 11.49
September 30, 2024 9.142
June 30, 2024 8.006
March 31, 2024 6.677
December 31, 2023 5.685
September 30, 2023 5.418
June 30, 2023 7.088
March 31, 2023 6.189
December 31, 2022 6.800
September 30, 2022 6.658
June 30, 2022 6.271
March 31, 2022 6.743
December 31, 2021 6.129
September 30, 2021 6.551
June 30, 2021 6.658
March 31, 2021 6.681
December 31, 2020 6.793
September 30, 2020 6.109
June 30, 2020 6.148
Date Value
March 31, 2020 6.038
December 31, 2019 5.011
September 30, 2019 4.436
June 30, 2019 4.137
March 31, 2019 2.477
December 31, 2018 3.018
September 30, 2018 0.4511
June 30, 2018 -0.0845
March 31, 2018 1.086
December 31, 2017 -0.1263
September 30, 2017 2.081
June 30, 2017 2.281
March 31, 2017 2.041
December 31, 2016 2.551
September 30, 2016 2.283
June 30, 2016 2.303
March 31, 2016 2.153
December 31, 2015 2.243
September 30, 2015 2.21
June 30, 2015 1.93
March 31, 2015 2.05
December 31, 2014 2.23
September 30, 2014 2.50
June 30, 2014 3.14
March 31, 2014 3.57

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Johnson & Johnson 8.628
Merck & Co., Inc. 1.251
Pfizer Inc. 0.7552
Bristol Myers Squibb Co. 4.539
Atai Beckley, Inc. -2.188